{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:05:25Z","timestamp":1785247525326,"version":"3.55.0"},"reference-count":264,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health","award":["R01 CA210192, R01 CA206069, and SC1GM139727"],"award-info":[{"award-number":["R01 CA210192, R01 CA206069, and SC1GM139727"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Chemotherapy is one of the prime treatment options for cancer. However, the key issues with traditional chemotherapy are recurrence of cancer, development of resistance to chemotherapeutic agents, affordability, late-stage detection, serious health consequences, and inaccessibility. Hence, there is an urgent need to find innovative and cost-effective therapies that can target multiple gene products with minimal adverse reactions. Natural phytochemicals originating from plants constitute a significant proportion of the possible therapeutic agents. In this article, we reviewed the advances and the potential of Withania somnifera (WS) as an anticancer and immunomodulatory molecule. Several preclinical studies have shown the potential of WS to prevent or slow the progression of cancer originating from various organs such as the liver, cervix, breast, brain, colon, skin, lung, and prostate. WS extracts act via various pathways and provide optimum effectiveness against drug resistance in cancer. However, stability, bioavailability, and target specificity are major obstacles in combination therapy and have limited their application. The novel nanotechnology approaches enable solubility, stability, absorption, protection from premature degradation in the body, and increased circulation time and invariably results in a high differential uptake efficiency in the phytochemical\u2019s target cells. The present review primarily emphasizes the insights of WS source, chemistry, and the molecular pathways involved in tumor regression, as well as developments achieved in the delivery of WS for cancer therapy using nanotechnology. This review substantiates WS as a potential immunomodulatory, anticancer, and chemopreventive agent and highlights its potential use in cancer treatment.<\/jats:p>","DOI":"10.3390\/pharmaceutics14030611","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T20:19:10Z","timestamp":1646943550000},"page":"611","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics"],"prefix":"10.3390","volume":"14","author":[{"given":"Vivek K.","family":"Kashyap","sequence":"first","affiliation":[{"name":"Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"},{"name":"South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-0522","authenticated-orcid":false,"given":"Godwin","family":"Peasah-Darkwah","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"},{"name":"South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Dhasmana","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"},{"name":"South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Jaggi","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"},{"name":"South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-8828","authenticated-orcid":false,"given":"Murali M.","family":"Yallapu","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"},{"name":"South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash C.","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"},{"name":"South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"(2022, March 03). The Centers for Disease Control and Prevention, an Update on Cancer Deaths in the United States, Available online: https:\/\/www.cdc.gov\/cancer\/dcpc\/research\/update-on-cancer-deaths\/index.htm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2017.12.014","article-title":"Therapeutic potential of gambogic acid, a caged xanthone, to target cancer","volume":"416","author":"Banik","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fphar.2018.00686","article-title":"Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases","volume":"9","author":"Kunnumakkara","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2015.03.033","article-title":"Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-\u03baB signaling cascade in gastric cancer","volume":"363","author":"Manu","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1158\/1078-0432.CCR-11-2470","article-title":"First evidence that \u03b3-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-\u03baB pathway","volume":"18","author":"Manu","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Seca, A.M.L., and Pinto, D. (2018). Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010263"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2016.03.005","article-title":"Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds","volume":"40\u201341","author":"Shanmugam","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2016.03.002","article-title":"Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases","volume":"40\u201341","author":"Patel","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4314\/ajtcam.v8i5S.9","article-title":"An overview on ashwagandha: A Rasayana (rejuvenator) of Ayurveda","volume":"8","author":"Singh","year":"2011","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-8741(97)00151-7","article-title":"Effect of ashwagandha on lipid peroxidation in stress-induced animals","volume":"60","author":"Dhuley","year":"1998","journal-title":"J. Ethnopharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1080\/01635581.2020.1778746","article-title":"Mechanisms of Anti-Tumor Activity of Withania somnifera (Ashwagandha)","volume":"73","author":"Mehta","year":"2021","journal-title":"Nutr. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/13880209.2015.1027778","article-title":"Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives","volume":"54","author":"Rai","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dutta, R., Khalil, R., Green, R., Mohapatra, S.S., and Mohapatra, S. (2019). Withania somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215310"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"Fdd50","DOI":"10.4155\/fdd-2020-0024","article-title":"Withania somnifera as a potential future drug molecule for COVID-19","volume":"2","author":"Kashyap","year":"2020","journal-title":"Future Drug Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11064-020-03146-4","article-title":"Neuroprotective Effects of Withania somnifera on 4-Hydroxynonenal Induced Cell Death in Human Neuroblastoma SH-SY5Y Cells Through ROS Inhibition and Apoptotic Mitochondrial Pathway","volume":"46","author":"Siddiqui","year":"2021","journal-title":"Neurochem. Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Peng, S.Y., Wang, Y.Y., Lan, T.H., Lin, L.C., Yuan, S.F., Tang, J.Y., and Chang, H.W. (2020). Low Dose Combined Treatment with Ultraviolet-C and Withaferin a Enhances Selective Killing of Oral Cancer Cells. Antioxidants, 9.","DOI":"10.3390\/antiox9111120"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s11011-021-00745-0","article-title":"Withania coagulans extract attenuates oxidative stress-mediated apoptosis of cerebellar purkinje neurons after ischemia\/reperfusion injury","volume":"36","author":"Heidari","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhang, X., Mukerji, R., Samadi, A.K., and Cohen, M.S. (2011). Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells. BMC Complement. Altern. Med., 11.","DOI":"10.1186\/1472-6882-11-84"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1158\/0008-5472.CAN-08-1510","article-title":"Withaferin A causes FOXO3a-and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo","volume":"68","author":"Stan","year":"2008","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cbi.2011.01.015","article-title":"Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition","volume":"190","author":"Yang","year":"2011","journal-title":"Chem.-Biol. Interact."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00262-013-1470-2","article-title":"Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract","volume":"62","author":"Sinha","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/1940-6207.CAPR-13-0445","article-title":"Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells","volume":"7","author":"Kim","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/carcin\/bgy109","article-title":"The chemopreventive effect of withaferin A on spontaneous and inflammation-associated colon carcinogenesis models","volume":"39","author":"Chandrasekaran","year":"2018","journal-title":"Carcinogenesis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.intimp.2009.02.002","article-title":"Withaferin A inhibits tumor necrosis factor-\u03b1-induced expression of cell adhesion molecules by inactivation of Akt and NF-\u03baB in human pulmonary epithelial cells","volume":"9","author":"Oh","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/gerona\/glz077","article-title":"Induction of Senescence in Cancer Cells by a Novel Combination of Cucurbitacin B and Withanone: Molecular Mechanism and Therapeutic Potential","volume":"75","author":"Garg","year":"2019","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fimmu.2018.00195","article-title":"Withaferin A Associated Differential Regulation of Inflammatory Cytokines","volume":"9","author":"Dubey","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"153949","DOI":"10.1016\/j.phymed.2022.153949","article-title":"Withania somnifera (L.) Dunal: Phytochemistry, structure-activity relationship, and anticancer potential","volume":"98","author":"Tewari","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/19390211.2017.1284970","article-title":"Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions","volume":"14","author":"Choudhary","year":"2017","journal-title":"J. Diet Suppl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/2156587216641830","article-title":"Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial","volume":"22","author":"Choudhary","year":"2017","journal-title":"J. Evid. Based Complement. Altern. Med."},{"key":"ref_31","first-page":"e6466","article-title":"Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study","volume":"11","author":"Salve","year":"2019","journal-title":"Cureus"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/0253-7176.106022","article-title":"A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults","volume":"34","author":"Chandrasekhar","year":"2012","journal-title":"Indian J. Psychol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.pnpbp.2007.09.011","article-title":"Withania somnifera: An Indian ginseng","volume":"32","author":"Kulkarni","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1007\/s00018-015-2012-1","article-title":"Pharmacologic overview of Withania somnifera, the Indian Ginseng","volume":"72","author":"Dar","year":"2015","journal-title":"Cell Mol. Life Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.phytochem.2015.02.029","article-title":"Hypoglycemic activity of withanolides and elicitated Withania somnifera","volume":"116","author":"Gorelick","year":"2015","journal-title":"Phytochemistry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/13880209.2013.835325","article-title":"Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats","volume":"52","author":"Gupta","year":"2014","journal-title":"Pharm. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.clnu.2008.05.006","article-title":"Withania somnifera provides cardioprotection and attenuates ischemia-reperfusion induced apoptosis","volume":"27","author":"Mohanty","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jep.2009.08.003","article-title":"Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson\u2019s disease model mouse","volume":"125","author":"RajaSankar","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Bhatnagar, M., Goel, I., Roy, T., Shukla, S.D., and Khurana, S. (2017). Complete Comparison Display (CCD) evaluation of ethanol extracts of Centella asiatica and Withania somnifera shows that they can non-synergistically ameliorate biochemical and behavioural damages in MPTP induced Parkinson\u2019s model of mice. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177254"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.parint.2013.01.007","article-title":"An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides","volume":"62","author":"Chandrasekaran","year":"2013","journal-title":"Parasitol. Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s00436-013-3387-2","article-title":"Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis","volume":"112","author":"Sachdeva","year":"2013","journal-title":"Parasitol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2012.11.016","article-title":"Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress","volume":"56","author":"Reuland","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_43","first-page":"488","article-title":"Review of biological activity of withanolides","volume":"46","author":"Budhiraja","year":"1987","journal-title":"J. Sci. Ind. Res."},{"key":"ref_44","unstructured":"Rastogi RP, M.B. (1998). Compendium of Indian Medicinal Plants, Central Drug Research Institute."},{"key":"ref_45","unstructured":"Bone, K. (1996). Clinical applications of Ayurvedic and Chinese herbs. Monograph for the Western Herbal Practitioner, Phytotherapy Press."},{"key":"ref_46","first-page":"385","article-title":"New data referring to chemistry of Withania somnifera species","volume":"94","author":"Elsakka","year":"1990","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Iasi"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF02637735","article-title":"Gas chromatographic identification of fatty acids, fatty alcohols, and hydrocarbons of Convolvulus pluricaulis (Chois)","volume":"52","author":"Srivastava","year":"1975","journal-title":"J. Am. Oil Chem. Soc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10565-016-9340-2","article-title":"Assessment of hepatoprotective and nephroprotective potential of withaferin A on bromobenzene-induced injury in Swiss albino mice: Possible involvement of mitochondrial dysfunction and inflammation","volume":"32","author":"Vedi","year":"2016","journal-title":"Cell Biol. Toxicol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lfs.2018.09.020","article-title":"Withaferin A inhibits apoptosis via activated Akt-mediated inhibition of oxidative stress","volume":"211","author":"Yan","year":"2018","journal-title":"Life Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/ptr.6200","article-title":"Withaferin A, a novel compound of Indian ginseng (Withania somnifera), ameliorates Cerulein-induced acute pancreatitis: Possible role of oxidative stress and inflammation","volume":"32","author":"Tiruveedi","year":"2018","journal-title":"Phytother. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2016.10.003","article-title":"Withaferin A induces Nrf2-dependent protection against liver injury: Role of Keap1-independent mechanisms","volume":"101","author":"Palliyaguru","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/biof.1446","article-title":"Withaferin A attenuates bleomycin-induced scleroderma by targeting FoxO3a and NF-\u03ba\u03b2 signaling: Connecting fibrosis and inflammation","volume":"44","author":"Bale","year":"2018","journal-title":"Biofactors"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00709-014-0701-5","article-title":"Modulation of liver and kidney toxicity by herb Withania somnifera for silver nanoparticles: A novel approach for harmonizing between safety and use of nanoparticles","volume":"252","author":"Anwar","year":"2015","journal-title":"Protoplasma"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1534735412464551","article-title":"Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients","volume":"12","author":"Biswal","year":"2013","journal-title":"Integr. Cancer Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ygyno.2011.11.044","article-title":"Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A","volume":"124","author":"Zhang","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.25938","article-title":"Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation","volume":"129","author":"Thaiparambil","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s10495-008-0273-y","article-title":"Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation","volume":"13","author":"Oh","year":"2008","journal-title":"Apoptosis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/1078-0432.CCR-06-0948","article-title":"Selective killing of cancer cells by leaf extract of Ashwagandha: Identification of a tumor-inhibitory factor and the first molecular insights to its effect","volume":"13","author":"Widodo","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2007.11.037","article-title":"Selective killing of cancer cells by leaf extract of Ashwagandha: Components, activity and pathway analyses","volume":"262","author":"Widodo","year":"2008","journal-title":"Cancer Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/mol.106.030015","article-title":"The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from \u201cIndian winter cherry\u201d","volume":"71","author":"Yang","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.surg.2010.09.026","article-title":"A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo","volume":"148","author":"Samadi","year":"2010","journal-title":"Surgery"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Yang, H., Wang, Y., Cheryan, V.T., Wu, W., Cui, C.Q., Polin, L.A., Pass, H.I., Dou, Q.P., Rishi, A.K., and Wali, A. (2012). Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041214"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bcp.2009.09.017","article-title":"Withaferin A targets heat shock protein 90 in pancreatic cancer cells","volume":"79","author":"Yu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_64","first-page":"16","article-title":"Protective effect of Withaferin-A on tumour formation in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis in hamsters","volume":"47","author":"Manoharan","year":"2009","journal-title":"Indian J. Exp. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mc.22050","article-title":"Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells","volume":"53","author":"Hahm","year":"2014","journal-title":"Mol. Carcinog."},{"key":"ref_66","first-page":"169","article-title":"In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma 180","volume":"30","author":"Devi","year":"1992","journal-title":"Indian J. Exp. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/carcin\/bgr192","article-title":"Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells","volume":"32","author":"Munagala","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.bbrc.2018.06.162","article-title":"Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cells","volume":"503","author":"Xia","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11060-015-1972-1","article-title":"AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models","volume":"126","author":"Chang","year":"2016","journal-title":"J. Neurooncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1080\/15548627.2016.1191722","article-title":"Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells","volume":"12","author":"Li","year":"2016","journal-title":"Autophagy"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s10495-008-0271-0","article-title":"Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade","volume":"13","author":"Mandal","year":"2008","journal-title":"Apoptosis"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s10495-007-0129-x","article-title":"Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine","volume":"12","author":"Malik","year":"2007","journal-title":"Apoptosis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/0008-5472.CAN-06-2430","article-title":"Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells","volume":"67","author":"Srinivasan","year":"2007","journal-title":"Cancer Res."},{"key":"ref_74","first-page":"625","article-title":"In vitro antiproliferative activity of partially purified Withania somnifera fruit extract on different cancer cell lines","volume":"20","author":"Abutaha","year":"2015","journal-title":"J. Balkan Union Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10456-004-1026-3","article-title":"Withaferin A is a potent inhibitor of angiogenesis","volume":"7","author":"Mohan","year":"2004","journal-title":"Angiogenesis"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1177\/0300060517752022","article-title":"Antioxidant activity and apoptotic induction as mechanisms of action of Withania somnifera (Ashwagandha) against a hepatocellular carcinoma cell line","volume":"46","author":"Ahmed","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e2755","DOI":"10.1038\/cddis.2017.33","article-title":"Withaferin-A kills cancer cells with and without telomerase: Chemical, computational and experimental evidences","volume":"8","author":"Yu","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s10495-011-0625-x","article-title":"Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2","volume":"16","author":"Mayola","year":"2011","journal-title":"Apoptosis"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Hsu, J.H., Chang, P.M., Cheng, T.S., Kuo, Y.L., Wu, A.T., Tran, T.H., Yang, Y.H., Chen, J.M., Tsai, Y.C., and Chu, Y.S. (2019). Identification of Withaferin A as a Potential Candidate for Anti-Cancer Therapy in Non-Small Cell Lung Cancer. Cancers, 11.","DOI":"10.3390\/cancers11071003"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/15384047.2015.1046651","article-title":"Anti-cancer activity of withaferin A in B-cell lymphoma","volume":"16","author":"McKenna","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Nishikawa, Y., Okuzaki, D., Fukushima, K., Mukai, S., Ohno, S., Ozaki, Y., Yabuta, N., and Nojima, H. (2015). Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134137"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bcp.2014.06.022","article-title":"Withaferin A modulates the Spindle assembly checkpoint by degradation of Mad2-Cdc20 complex in colorectal cancer cell lines","volume":"91","author":"Das","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Vaishnavi, K., Saxena, N., Shah, N., Singh, R., Manjunath, K., Uthayakumar, M., Kanaujia, S.P., Kaul, S.C., Sekar, K., and Wadhwa, R. (2012). Differential Activities of the Two Closely Related Withanolides, Withaferin A and Withanone: Bioinformatics and Experimental Evidences. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044419"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Sari, A.N., Bhargava, P., Dhanjal, J.K., Putri, J.F., Radhakrishnan, N., Shefrin, S., Ishida, Y., Terao, K., Sundar, D., and Kaul, S.C. (2020). Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action. Cancers, 12.","DOI":"10.3390\/cancers12051160"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13046-019-1099-x","article-title":"Wild type p53 function in p53Y220C mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: Bioinformatics and experimental evidence","volume":"38","author":"Sundar","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.phytochem.2010.08.019","article-title":"Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line","volume":"71","author":"Choudhary","year":"2010","journal-title":"Phytochemistry"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s12010-009-8667-z","article-title":"Anticancer properties of highly purified L-asparaginase from Withania somnifera L. against acute lymphoblastic leukemia","volume":"160","author":"Oza","year":"2010","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ptr.1378","article-title":"Effect of Withania somnifera on B16F-10 melanoma induced metastasis in mice","volume":"18","author":"Leyon","year":"2004","journal-title":"Phytother. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jep.2006.02.016","article-title":"Selective Th1 up-regulating activity of Withania somnifera aqueous extract in an experimental system using flow cytometry","volume":"107","author":"Bani","year":"2006","journal-title":"J. Ethnopharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1248\/cpb.50.760","article-title":"Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities","volume":"50","author":"Zhao","year":"2002","journal-title":"Chem. Pharm. Bull."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Wadhwa, R., Singh, R., Gao, R., Shah, N., Widodo, N., Nakamoto, T., Ishida, Y., Terao, K., and Kaul, S.C. (2013). Water Extract of Ashwagandha Leaves Has Anticancer Activity: Identification of an Active Component and Its Mechanism of Action. PLoS ONE, 8.","DOI":"10.1371\/annotation\/b7059f27-5970-4734-8601-9913adcce984"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lfs.2003.07.007","article-title":"Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves","volume":"74","author":"Jayaprakasam","year":"2003","journal-title":"Life Sci."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Rah, B., Amin, H., Yousuf, K., Khan, S., Jamwal, G., Mukherjee, D., and Goswami, A. (2012). A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044039"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Wang, H.-C., Tsai, Y.-L., Wu, Y.-C., Chang, F.-R., Liu, M.-H., Chen, W.-Y., and Wu, C.-C. (2012). Withanolides-Induced Breast Cancer Cell Death Is Correlated with Their Ability to Inhibit Heat Protein 90. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037764"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.phymed.2018.09.017","article-title":"Different effects of 4\u03b2-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells","volume":"53","author":"Wang","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2147\/DDDT.S130601","article-title":"Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer","volume":"11","author":"Yadav","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1476-4598-9-239","article-title":"Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase","volume":"9","author":"Mondal","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fphar.2017.00610","article-title":"Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma Cells","volume":"8","author":"Issa","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"267614","DOI":"10.1093\/ecam\/nep188","article-title":"Water extract of ashwagandha leaves limits proliferation and migration, and induces differentiation in glioma cells","volume":"2011","author":"Kataria","year":"2011","journal-title":"Evid.-Based Complement. Altern."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Widodo, N., Priyandoko, D., Shah, N., Wadhwa, R., and Kaul, S.C. (2010). Selective Killing of Cancer Cells by Ashwagandha Leaf Extract and Its Component Withanone Involves ROS Signaling. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013536"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jtcme.2020.02.002","article-title":"Withania somnifera root extract inhibits fatty acid synthesis in prostate cancer cells","volume":"10","author":"Kim","year":"2020","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.prnil.2017.03.002","article-title":"Withania somnifera targets interleukin-8 and cyclooxygenase-2 in human prostate cancer progression","volume":"5","author":"Nathan","year":"2017","journal-title":"Prostate Int."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Henley, A.B., Yang, L., Chuang, K.-L., Sahuri-Arisoylu, M., Wu, L.-H., Bligh, S.W.A., and Bell, J.D. (2017). Withania somnifera Root Extract Enhances Chemotherapy through \u2018Priming\u2019. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170917"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/17425255.2019.1650914","article-title":"Is curcumin bioavailability a problem in humans: Lessons from clinical trials","volume":"15","author":"Kunnumakkara","year":"2019","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e4573","DOI":"10.1002\/bmc.4573","article-title":"Studies on oral bioavailability and first-pass metabolism of withaferin A in rats using LC-MS\/MS and Q-TRAP","volume":"33","author":"Dai","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jpba.2013.03.001","article-title":"Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetics after oral administration of Withania somnifera aqueous extract","volume":"80","author":"Patil","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cbi.2005.11.003","article-title":"Enhancement of antitumor effect of paclitaxel in combination with immunomodulatory Withania somnifera on benzo (a) pyrene induced experimental lung cancer","volume":"159","author":"Senthilnathan","year":"2006","journal-title":"Chem.-Biol. Interact."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1349-7006.2006.00224.x","article-title":"Chemotherapeutic efficacy of paclitaxel in combination with Withania somnifera on benzo (a) pyrene-induced experimental lung cancer","volume":"97","author":"Senthilnathan","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.7314\/APJCP.2014.15.4.1711","article-title":"Effect of Withaferin A on A549 cellular proliferation and apoptosis in non-small cell lung cancer","volume":"15","author":"Cai","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"15737","DOI":"10.1038\/s41598-018-34018-1","article-title":"Withaferin A inhibits Epithelial to Mesenchymal Transition in Non-Small Cell Lung Cancer Cells","volume":"8","author":"Kyakulaga","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.breast.2015.06.001","article-title":"Features of aggressive breast cancer","volume":"24","author":"Arpino","year":"2015","journal-title":"Breast"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/01635580802381477","article-title":"Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells","volume":"60","author":"Stan","year":"2008","journal-title":"Nutr. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2012.08.026","article-title":"Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression","volume":"334","author":"Hahm","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Hahm, E.-R., Moura, M.B., Kelley, E.E., Van Houten, B., Shiva, S., and Singh, S.V. (2011). Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023354"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2007.04.010","article-title":"The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin","volume":"14","author":"Hamza","year":"2007","journal-title":"Chem. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Yang, Z., Garcia, A., Xu, S., Powell, D.R., Vertino, P.M., Singh, S., and Marcus, A.I. (2013). Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075069"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/2394-4722.157601","article-title":"Withania somnifera extract reduces the invasiveness of MDA-MB-231 breast cancer and inhibits cytokines associated with metastasis","volume":"1","author":"Khazal","year":"2015","journal-title":"J. Cancer Metastasis Treat."},{"key":"ref_119","first-page":"1519","article-title":"Effect of an extract of Withania somnifera root on estrogen receptor-positive mammary carcinomas","volume":"33","author":"Khazal","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mc.20760","article-title":"Withaferin a suppresses estrogen receptor-\u03b1 expression in human breast cancer cells","volume":"50","author":"Hahm","year":"2011","journal-title":"Mol. Carcinog."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/mc.22110","article-title":"Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors","volume":"54","author":"Lee","year":"2015","journal-title":"Mol. Carcinog."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1093\/carcin\/bgq175","article-title":"Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells","volume":"31","author":"Lee","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_123","first-page":"987","article-title":"Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation","volume":"23","author":"Mulabagal","year":"2009","journal-title":"Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10549-012-2239-6","article-title":"Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells","volume":"136","author":"Lee","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1158\/0008-5472.CAN-13-2081","article-title":"Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer","volume":"74","author":"Nagalingam","year":"2014","journal-title":"Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"40434","DOI":"10.18632\/oncotarget.17107","article-title":"Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A","volume":"8","author":"Declerck","year":"2017","journal-title":"Oncotarget"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/np400441f","article-title":"Withaferin A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells","volume":"76","author":"Roy","year":"2013","journal-title":"J. Nat. Prod."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/cas.13266","article-title":"Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters","volume":"108","author":"Kunimasa","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3109\/08820139.2010.487083","article-title":"Immunomodulatory effects of Withania somnifera on azoxymethane induced experimental colon cancer in mice","volume":"39","author":"Muralikrishnan","year":"2010","journal-title":"Immunol. Investig."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/1535-7163.MCT-09-0771","article-title":"Notch-1 inhibition by Withaferin-A: A therapeutic target against colon carcinogenesis","volume":"9","author":"Koduru","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"185","DOI":"10.15430\/JCP.2015.20.3.185","article-title":"Withaferin-A inhibits colon cancer cell growth by blocking STAT3 transcriptional activity","volume":"20","author":"Choi","year":"2015","journal-title":"J. Cancer Prev."},{"key":"ref_132","first-page":"799","article-title":"Synergistic antitumor effect of 5-fluorouracil and withaferin-A induces endoplasmic reticulum stress-mediated autophagy and apoptosis in colorectal cancer cells","volume":"10","author":"Alnuqaydan","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.tiv.2011.09.016","article-title":"Combination of withaferin A and X-ray irradiation enhances apoptosis in U937 cells","volume":"25","author":"Yang","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/cas.12988","article-title":"Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression","volume":"107","author":"Okamoto","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Turrini, E., Calcabrini, C., Sestili, P., Catanzaro, E., de Gianni, E., Diaz, A.R., Hrelia, P., Tacchini, M., Guerrini, A., and Canonico, B. (2016). Withania somnifera Induces Cytotoxic and Cytostatic Effects on Human T Leukemia Cells. Toxins, 8.","DOI":"10.3390\/toxins8050147"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1207\/S15327914NC421_12","article-title":"Withania somnifera root extract prevents DMBA-induced squamous cell carcinoma of skin in Swiss albino mice","volume":"42","author":"Prakash","year":"2002","journal-title":"Nutr. Cancer."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3389\/fphys.2017.00634","article-title":"Withaferin A induces oxidative stress-mediated apoptosis and DNA damage in oral cancer cells","volume":"8","author":"Chang","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3892\/etm.2015.2480","article-title":"Antiproliferation potential of withaferin A on human osteosarcoma cells via the inhibition of G2\/M checkpoint proteins","volume":"10","author":"Lv","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3892\/ol.2017.6169","article-title":"Withaferin A inhibits the proliferation of gastric cancer cells by inducing G2\/M cell cycle arrest and apoptosis","volume":"14","author":"Kim","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.canlet.2014.11.026","article-title":"Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K\/AKT pathway in human pancreatic cancer cells","volume":"357","author":"Li","year":"2015","journal-title":"Cancer lett."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Fong, M.Y., Jin, S., Rane, M., Singh, R.K., Gupta, R., and Kakar, S.S. (2012). Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042265"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Kakar, S.S., Ratajczak, M.Z., Powell, K.S., Moghadamfalahi, M., Miller, D.M., Batra, S.K., and Singh, S.K. (2014). Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107596"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3892\/or.2013.2487","article-title":"Withaferin A inhibits matrix metalloproteinase-9 activity by suppressing the Akt signaling pathway","volume":"30","author":"Lee","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbrc.2012.08.133","article-title":"Withaferin A inhibits JAK\/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells","volume":"427","author":"Um","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.tiv.2011.01.010","article-title":"Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells","volume":"25","author":"Choi","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bcp.2014.08.004","article-title":"Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKK\u03b2","volume":"91","author":"Heyninck","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"104331","DOI":"10.1016\/j.phrs.2019.104331","article-title":"The potential of retinoids for combination therapy of lung cancer: Updates and future directions","volume":"147","author":"Tripathi","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.18632\/oncotarget.27519","article-title":"Synergistic combinations of paclitaxel and withaferin A against human non-small cell lung cancer cells","volume":"11","author":"Kyakulaga","year":"2020","journal-title":"Oncotarget"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1476-4598-9-99","article-title":"Differential chemosensitization of P-glycoprotein overexpressing K562\/Adr cells by withaferin A and Siamois polyphenols","volume":"9","author":"Suttana","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/15548627.2015.1017182","article-title":"PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells","volume":"11","author":"Rah","year":"2015","journal-title":"Autophagy"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10637-012-9888-5","article-title":"Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt\/mTOR and MAPK signaling pathways","volume":"31","author":"Grogan","year":"2013","journal-title":"Investig. New Drugs"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s10637-014-0084-7","article-title":"Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt\/mTOR pathway inhibitory modulation","volume":"32","author":"Grogan","year":"2014","journal-title":"Investig. New Drugs."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12017-016-8411-0","article-title":"Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells","volume":"18","author":"Sun","year":"2016","journal-title":"Neuromolecular Med."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Kataria, H., Wadhwa, R., Kaul, S.C., and Kaur, G. (2013). Withania somnifera water extract as a potential candidate for differentiation based therapy of human neuroblastomas. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055316"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1007\/s12035-015-9320-1","article-title":"Withania somnifera Suppresses Tumor Growth of Intracranial Allograft of Glioma Cells","volume":"53","author":"Kataria","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_156","first-page":"29","article-title":"Withaferin A targeting both cancer stem cells and metastatic cancer stem cells in the UP-LN1 carcinoma cell model","volume":"2","author":"Ting","year":"2016","journal-title":"J. Cancer Metastatis Treat."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjsurg.2012.07.027","article-title":"A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers","volume":"204","author":"Cohen","year":"2012","journal-title":"Am. J. Surg."},{"key":"ref_158","unstructured":"(2022, March 03). Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma (OSCAT), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00689195?term=Withania+somnifera&cond=cancer&draw=2&rank=3."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ptr.2889","article-title":"In vivo enhancement of natural killer cell activity through tea fortified with Ayurvedic herbs","volume":"24","author":"Bhat","year":"2010","journal-title":"Phytother. Res."},{"key":"ref_160","unstructured":"(2022, March 03). Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00817752?term=Withania+somnifera&cond=cancer&draw=2&rank=2."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"22496","DOI":"10.4088\/JCP.17m11826","article-title":"Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study","volume":"79","author":"Chengappa","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/19390211.2020.1741484","article-title":"Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects","volume":"18","author":"Namdeo","year":"2021","journal-title":"J. Diet Suppl."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Khanal, P., Chikhale, R., Dey, Y.N., Pasha, I., Chand, S., Gurav, N., Ayyanar, M., Patil, B.M., and Gurav, S. (2021). Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19. J. Biomol. Struct. Dyn.","DOI":"10.21203\/rs.3.rs-32955\/v1"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jep.2016.07.080","article-title":"Network ethnopharmacological evaluation of the immunomodulatory activity of Withania somnifera","volume":"197","author":"Chandran","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu Rev. Immunol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bcp.2012.08.027","article-title":"Molecular insight in the multifunctional activities of Withaferin A","volume":"84","author":"Sabbe","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0024-3205(02)02472-4","article-title":"Induction of nitric oxide synthase expression by Withania somnifera in macrophages","volume":"72","author":"Iuvone","year":"2003","journal-title":"Life Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.intimp.2011.02.029","article-title":"Withaferin A down-regulates lipopolysaccharide-induced cyclooxygenase-2 expression and PGE2 production through the inhibition of STAT1\/3 activation in microglial cells","volume":"11","author":"Min","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ptr.2180","article-title":"Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells","volume":"21","author":"Singh","year":"2007","journal-title":"Phytother. Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1078\/0944-7113-00021","article-title":"Indian medicinal plants as antiradicals and DNA cleavage protectors","volume":"8","author":"Russo","year":"2001","journal-title":"Phytomedicine"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-8741(99)00206-8","article-title":"Immunomodulatory activity of Withania somnifera","volume":"71","author":"Davis","year":"2000","journal-title":"J. Ethnopharmacol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0378-8741(95)01318-0","article-title":"Studies on the immunomodulatory effects of Ashwagandha","volume":"50","author":"Ziauddin","year":"1996","journal-title":"J. Ethnopharmacol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2008.09.017","article-title":"Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells","volume":"599","author":"Oh","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpb.2021.03.010","article-title":"Nanotechnology synergized immunoengineering for cancer","volume":"163","author":"Chauhan","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"8982","DOI":"10.1021\/acsomega.0c00793","article-title":"Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy","volume":"5","author":"Shetty","year":"2020","journal-title":"ACS Omega"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Samanta, K., Setua, S., Kumari, S., Jaggi, M., Yallapu, M.M., and Chauhan, S.C. (2019). Gemcitabine Combination Nano Therapies for Pancreatic Cancer. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11110574"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"102027","DOI":"10.1016\/j.nano.2019.102027","article-title":"Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment","volume":"20","author":"Massey","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Kim, B., Park, J.E., Im, E., Cho, Y., Lee, J., Lee, H.J., Sim, D.Y., Park, W.Y., Shim, B.S., and Kim, S.H. (2021). Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073571"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Salama, L., Pastor, E.R., Stone, T., and Mousa, S.A. (2020). Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management. Biomedicines, 8.","DOI":"10.3390\/biomedicines8090347"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"5813793","DOI":"10.1155\/2017\/5813793","article-title":"Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems","volume":"2017","author":"Granja","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3389\/fphar.2017.01002","article-title":"PhytoNanotechnology: Enhancing Delivery of Plant Based Anti-cancer Drugs","volume":"8","author":"Khan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biomaterials.2019.04.005","article-title":"Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer","volume":"208","author":"Khan","year":"2019","journal-title":"Biomaterials"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Nagesh, P.K.B., Chowdhury, P., Hatami, E., Boya, V.K.N., Kashyap, V.K., Khan, S., Hafeez, B.B., Chauhan, S.C., Jaggi, M., and Yallapu, M.M. (2018). miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy. Cancers, 10.","DOI":"10.3390\/cancers10090289"},{"key":"ref_187","unstructured":"(2022, March 03). Nanomedicine Market Is Estimated To Be Valued At $350.8 Billion By 2025: Grand View Research, Inc. Available online: https:\/\/www.grandviewresearch.com\/press-release\/global-nanomedicine-market."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1208\/s12248-015-9780-2","article-title":"A Review of Clinical Translation of Inorganic Nanoparticles","volume":"17","author":"Anselmo","year":"2015","journal-title":"AAPS J."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1039\/C9SC02107H","article-title":"Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy","volume":"10","author":"Zhang","year":"2019","journal-title":"Chem. Sci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nantod.2019.03.006","article-title":"Inherent multifunctional inorganic nanomaterials for imaging-guided cancer therapy","volume":"26","author":"Ju","year":"2019","journal-title":"Nano Today"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nantod.2019.04.005","article-title":"Designing inorganic nanomaterials for vaccines and immunotherapies","volume":"27","author":"Hess","year":"2019","journal-title":"Nano Today"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1002\/adma.201503280","article-title":"Recent advances in upconversion nanoparticles-based multifunctional nanocomposites for combined cancer therapy","volume":"27","author":"Tian","year":"2015","journal-title":"Adv. Mater."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"012001","DOI":"10.1088\/0957-4484\/25\/1\/012001","article-title":"Applications of inorganic nanoparticles as therapeutic agents","volume":"25","author":"Kim","year":"2013","journal-title":"Nanotechnology"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1021\/ar2000327","article-title":"Functionalization of inorganic nanoparticles for bioimaging applications","volume":"44","author":"Erathodiyil","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/adma.200802366","article-title":"Inorganic nanoparticles for MRI contrast agents","volume":"21","author":"Na","year":"2009","journal-title":"Adv. Mater."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/nn506137n","article-title":"Bismuth sulfide nanorods as a precision nanomedicine for in vivo multimodal imaging-guided photothermal therapy of tumor","volume":"9","author":"Liu","year":"2015","journal-title":"ACS Nano"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/adma.201104741","article-title":"Mn2+ dopant-controlled synthesis of NaYF4: Yb\/Er upconversion nanoparticles for in vivo imaging and drug delivery","volume":"24","author":"Tian","year":"2012","journal-title":"Adv. Mater."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1701268","DOI":"10.1002\/adma.201701268","article-title":"Poly(Vinylpyrollidone)- and Selenocysteine-Modified Bi(2) Se(3) Nanoparticles Enhance Radiotherapy Efficacy in Tumors and Promote Radioprotection in Normal Tissues","volume":"29","author":"Du","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"15736","DOI":"10.1021\/ja0386905","article-title":"Semiconductor quantum dots for photodynamic therapy","volume":"125","author":"Samia","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.drudis.2007.06.002","article-title":"Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug\/gene delivery applications","volume":"12","author":"Son","year":"2007","journal-title":"Drug Discov. Today"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/acs.nanolett.8b04763","article-title":"Tumor Microenvironment-Responsive Cu(2)(OH)PO(4) Nanocrystals for Selective and Controllable Radiosentization via the X-ray-Triggered Fenton-like Reaction","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"e1800662","DOI":"10.1002\/adma.201800662","article-title":"Graphene-Based Smart Platforms for Combined Cancer Therapy","volume":"31","author":"Gu","year":"2019","journal-title":"Adv. Mater."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"e1804046","DOI":"10.1002\/adma.201804046","article-title":"X-Ray-Controlled Generation of Peroxynitrite Based on Nanosized LiLuF(4): Ce(3+) Scintillators and their Applications for Radiosensitization","volume":"30","author":"Du","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s11426-018-9397-5","article-title":"Precise nanomedicine for intelligent therapy of cancer","volume":"61","author":"Chen","year":"2018","journal-title":"Sci. China Chem."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: A review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/aps.2011.82","article-title":"Gold nanoparticles in cancer therapy","volume":"32","author":"Lim","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijpharm.2015.02.038","article-title":"Current trends in using polymer coated gold nanoparticles for cancer therapy","volume":"484","author":"Muddineti","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.2147\/IJN.S258528","article-title":"Synthesis, Characterization and Anti-Cancer Therapeutic Potential of Withanolide-A with 20nm sAuNPs Conjugates Against SKBR3 Breast Cancer Cell Line","volume":"15","author":"Tabassam","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13058-019-1241-x","article-title":"Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation","volume":"22","author":"Wang","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.apt.2013.01.008","article-title":"Folate targeted PEGylated titanium dioxide nanoparticles as a nanocarrier for targeted paclitaxel drug delivery","volume":"24","author":"Ramasamy","year":"2013","journal-title":"Adv. Powder Technol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ultsonch.2010.12.017","article-title":"Sonodynamic therapy using water-dispersed TiO2-polyethylene glycol compound on glioma cells: Comparison of cytotoxic mechanism with photodynamic therapy","volume":"18","author":"Yamaguchi","year":"2011","journal-title":"Ultrason. Sonochem."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/41233","article-title":"Light-induced amphiphilic surfaces","volume":"388","author":"Wang","year":"1997","journal-title":"Nature"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1039\/c3cp43938k","article-title":"Recent progress in biomedical applications of titanium dioxide","volume":"15","author":"Yin","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s11671-015-0796-4","article-title":"A new strategy for TiO2 whiskers mediated multi-mode cancer treatment","volume":"10","author":"Xu","year":"2015","journal-title":"Nanoscale Res. Lett."},{"key":"ref_215","first-page":"275","article-title":"Cisplatin loaded hyaluronic acid modified TiO 2 nanoparticles for neoadjuvant chemotherapy of ovarian cancer","volume":"16","author":"Liu","year":"2015","journal-title":"J. Nanomater."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.micpath.2016.12.022","article-title":"Antibiofilm efficacy of green synthesized graphene oxide-silver nanocomposite using Lagerstroemia speciosa floral extract: A comparative study on inhibition of gram-positive and gram-negative biofilms","volume":"103","author":"Kulshrestha","year":"2017","journal-title":"Microb. Pathog."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"111667","DOI":"10.1016\/j.jphotobiol.2019.111667","article-title":"Synthesis of titanium oxide nanoparticles using Aloe barbadensis mill and evaluation of its antibiofilm potential against Pseudomonas aeruginosa PAO1","volume":"201","author":"Rajkumari","year":"2019","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_218","first-page":"26","article-title":"Aqueous Extract of Acanthophyllum laxiusculum Roots as a Renewable Resource for Green synthesis of nano-sized titanium dioxide using Sol-gel Method","volume":"2","author":"Madadi","year":"2016","journal-title":"Adv. Ceram. Prog."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.compositesb.2016.06.015","article-title":"Biomediated green synthesis of TiO2 nanoparticles for lithium ion battery application","volume":"99","author":"Kashale","year":"2016","journal-title":"Compos. B Eng."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1021\/cm00058a004","article-title":"Peptization Process in the Sol-Gel Preparation of Porous Anatase (TiO2)","volume":"7","author":"Bischoff","year":"1995","journal-title":"Chem. Mater."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1021\/acscombsci.5b00040","article-title":"Combinatorial Characterization of TiO2 Chemical Vapor Deposition Utilizing Titanium Isopropoxide","volume":"17","author":"Reinke","year":"2015","journal-title":"ACS Comb. Sci."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1021\/la970952r","article-title":"Preparation of Ultrafine Titanium Dioxide Particles Using Hydrolysis and Condensation Reactions in the Inner Aqueous Phase of Reversed Micelles:\u2009 Effect of Alcohol Addition","volume":"14","author":"Sakai","year":"1998","journal-title":"Langmuir"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1021\/ic7009572","article-title":"An Effective Hydrothermal Route for the Synthesis of Multiple PDDA-Protected Noble-Metal Nanostructures","volume":"46","author":"Chen","year":"2007","journal-title":"Inorg. Chem."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1021\/am302903n","article-title":"Photocatalytic activity of hydrogenated TiO2","volume":"5","author":"Leshuk","year":"2013","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1021\/cr5001892","article-title":"Understanding TiO2 photocatalysis: Mechanisms and materials","volume":"114","author":"Schneider","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1021\/jp9626982","article-title":"Improved Photocatalytic Activity and Characterization of Mixed TiO2\/SiO2 and TiO2\/Al2O3 Materials","volume":"101","author":"Anderson","year":"1997","journal-title":"J. Phys. Chem."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1021\/acsaem.8b00171","article-title":"Laser Selective Photoactivation of Amorphous TiO2 Films to Anatase and\/or Rutile Crystalline Phases","volume":"1","author":"Benavides","year":"2018","journal-title":"ACS Appl. Energy Mater."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"19605","DOI":"10.1021\/acsami.6b04919","article-title":"Investigation of the Switching Mechanism in TiO2-Based RRAM: A Two-Dimensional EDX Approach","volume":"8","author":"Carta","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"10095","DOI":"10.1021\/cr400606n","article-title":"Titanium Dioxide Nanomaterials for Photovoltaic Applications","volume":"114","author":"Bai","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"110457","DOI":"10.1016\/j.msec.2019.110457","article-title":"Bio-modified TiO(2) nanoparticles with Withania somnifera, Eclipta prostrata and Glycyrrhiza glabra for anticancer and antibacterial applications","volume":"108","author":"Maheswari","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3389\/fmicb.2020.01680","article-title":"Phyto-Mediated Synthesis of Porous Titanium Dioxide Nanoparticles From Withania somnifera Root Extract: Broad-Spectrum Attenuation of Biofilm and Cytotoxic Properties Against HepG2 Cell Lines","volume":"11","author":"Husain","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.7150\/thno.45413","article-title":"Silver nanoparticles: Synthesis, medical applications and biosafety","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"key":"ref_233","first-page":"173","article-title":"Silver nanoparticles: Synthesis methods, bio-applications and properties","volume":"42","author":"Abbasi","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"S855","DOI":"10.1080\/21691401.2018.1517769","article-title":"Green synthesis of silver nanoparticles toward bio and medical applications: Review study","volume":"46","author":"Mousavi","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Kim, D., Amatya, R., Hwang, S., Lee, S., Min, K.A., and Shin, M.C. (2021). BSA-Silver Nanoparticles: A Potential Multimodal Therapeutics for Conventional and Photothermal Treatment of Skin Cancer. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040575"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.msec.2019.02.113","article-title":"Green and cost effective synthesis of silver nanoparticles from endangered medicinal plant Withania coagulans and their potential biomedical properties","volume":"100","author":"Tripathi","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2174\/1389201021666200702152000","article-title":"Synthesis, In-Vitro and In-Silico Evaluation of Silver Nanoparticles with Root Extract of Withania somnifera for Antibacterial Activity via Binding of Penicillin-Binding Protein-4","volume":"21","author":"Gaurav","year":"2020","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00449-021-02666-9","article-title":"Green synthesis of silver nanoparticles using Rhodiola imbricata and Withania somnifera root extract and their potential catalytic, antioxidant, cytotoxic and growth-promoting activities","volume":"45","author":"Kapoor","year":"2022","journal-title":"Bioprocess Biosyst. Eng."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5772\/63437","article-title":"ZnO Nanoparticles: A Promising Anticancer Agent","volume":"3","author":"Bisht","year":"2016","journal-title":"Nanobiomedicine"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2174\/1566524013666131111130058","article-title":"Biomedical applications of zinc oxide nanomaterials","volume":"13","author":"Zhang","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.3390\/ma7042833","article-title":"Zinc Oxide-From Synthesis to Application: A Review","volume":"7","author":"Jesionowski","year":"2014","journal-title":"Materials"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"e02729","DOI":"10.1016\/j.heliyon.2019.e02729","article-title":"NIR light active ternary modified ZnO nanocomposites for combined cancer therapy","volume":"5","author":"Vasuki","year":"2019","journal-title":"Heliyon"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1007\/s11033-019-04705-x","article-title":"Exploration of immunomodulatory and protective effect of Withania somnifera on trace metal oxide (zinc oxide nanoparticles) induced toxicity in Balb\/c mice","volume":"46","author":"Kumar","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"ref_244","first-page":"742","article-title":"Progress in nanomedicine: Approved and investigational nanodrugs","volume":"42","author":"Ventola","year":"2017","journal-title":"Pharm. Ther."},{"key":"ref_245","first-page":"512","article-title":"The nanomedicine revolution: Part 1: Emerging concepts","volume":"37","author":"Ventola","year":"2012","journal-title":"Pharm. Ther."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1517\/17425247.5.1.25","article-title":"Liposomal nanomedicines","volume":"5","author":"Fenske","year":"2008","journal-title":"Expert. Opin. Drug Deliv."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1021\/acs.chemrev.5b00116","article-title":"Clinical translation of nanomedicine","volume":"115","author":"Min","year":"2015","journal-title":"Chem. Rev."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"101008","DOI":"10.1016\/j.nantod.2020.101008","article-title":"Progress, challenges, and future of nanomedicine","volume":"35","author":"Zhang","year":"2020","journal-title":"Nano Today"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/bc000110v","article-title":"Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG\u2212 diortho ester\u2212 lipid conjugate","volume":"12","author":"Guo","year":"2001","journal-title":"Bioconjugate Chem."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/02652048.2011.646330","article-title":"Trigger release liposome systems: Local and remote controlled delivery?","volume":"29","author":"Bibi","year":"2012","journal-title":"J. Microencapsul."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-4157(92)90038-C","article-title":"Sterically stabilized liposomes","volume":"1113","author":"Woodle","year":"1992","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Biomembr."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0005-2736(89)90078-3","article-title":"Liposomes with prolonged circulation times: Factors affecting uptake by reticuloendothelial and other tissues","volume":"981","author":"Allen","year":"1989","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fphar.2013.00143","article-title":"The use of lipid-based nanocarriers for targeted pain therapies","volume":"4","author":"Hua","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jps.23773","article-title":"Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems","volume":"103","author":"Kraft","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Bulbake, U., Doppalapudi, S., Kommineni, N., and Khan, W. (2017). Liposomal formulations in clinical use: An updated review. Pharmaceutics, 9.","DOI":"10.3390\/pharmaceutics9020012"},{"key":"ref_257","first-page":"3309","article-title":"Application of liposomal technologies for delivery of platinum analogs in oncology","volume":"8","author":"Liu","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/bjc.2013.408","article-title":"A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer","volume":"109","author":"Ko","year":"2013","journal-title":"Br. J. Cancer."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jconrel.2012.09.006","article-title":"Liposomal paclitaxel formulations","volume":"163","author":"Koudelka","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00280-012-2048-y","article-title":"A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies","volume":"71","author":"Deeken","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.02.040","article-title":"Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities","volume":"277","author":"Belfiore","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/156720105774370159","article-title":"Ligand-targeted liposomes for cancer treatment","volume":"2","author":"Sapra","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.actbio.2016.01.018","article-title":"Highly efficient drug delivery systems based on functional supramolecular polymers: In vitro evaluation","volume":"33","author":"Cheng","year":"2016","journal-title":"Acta Biomater."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.nantod.2017.06.008","article-title":"Evolution and clinical translation of drug delivery nanomaterials","volume":"15","author":"Hassan","year":"2017","journal-title":"Nano Today"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/3\/611\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:34:37Z","timestamp":1760135677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/3\/611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":264,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["pharmaceutics14030611"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14030611","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]}}}